On October 23, 2022, PhaseBio Pharmaceuticals, Inc., filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware and is no longer operating.

Inquiries Regarding PhaseBio’s Bankruptcy Proceedings

Omni Agent Solutions

View Case
Inquiries Regarding Bentracimab

SFJ Pharmaceuticals

5000 Hopyard Road Suite 330, Pleasanton, CA 94588
Attn: Mr. Robert DeBenedetto, CEO

Inquires Regarding Elastin-Like Polypeptides, PB-1046, PB-1023 and PB-0139


1150 First Ave, Suite 511, King of Prussia, PA 19406
Attn: Mr. Kiho Chang, CEO

Inquiries regarding PB-6440

Jixing Pharmaceuticals

22F, JC Plaza, 1225 Nanjing West Road, Jing‘an District, Shanghai 200040
Attn: Ms. Sandy Mou, CEO